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Changes in the biomechanics of gait may alter the energy requirements of walking in Parkinson’s Disease (PD). This study
investigated economy of gait during submaximal treadmill walking in 79 subjects with mild to moderate PD and the relationship
between gait economy and 6-minute walk distance (6MW). Oxygen consumption (VO2) at the self-selected treadmill walking
speed averaged 64% of peak oxygen consumption (VO2 peak). Submaximal VO2 levels exceeded 70% of VO2 peak in 30% of
the subjects. Overall the mean submaximal VO2 was 51% higher than VO2 levels expected for the speed and grade consistent
with severe impairment in economy of gait. There was an inverse relationship between economy of gait and 6MW (r =− 0.31,
P<0.01) and with the self-selected walking speed (r =− 0.35, P<0.01). Thus, the impairment in economy of gait and decreased
physiologic reserve result in routine walking being performed at a high percentage of VO2 peak.
1.Introduction
Walking capacity is central to the performance of many
activities of daily living. Diﬃculty with walking is one
of the cardinal symptoms of Parkinson’s Disease (PD).
Alterations in the biomechanics of gait, such as decreased
stride length, increased stride length variability, and reduced
gait speed, are common even in early stages of PD [1–3].
Most often, PD patients attempt to compensate for short
steps by increasing gait cadence, thereby potentially altering
energy requirements. This higher energy cost of movement
is often referred to as a lower economy of gait and is a
functionofabnormalgaitpatternsthataccompanyagingand
neurological disability. Reduced economy of gait has been
associated with impaired function and fatigue in non-PD
populations [4–9], but there is currently scant information
on how parkinsonian gait aﬀects energy expenditure or
economy of gait using direct measures of oxygen consump-
tion [10]. Further, little is known about the relationship
between economy of gait and mobility. Hence, the purpose
of this study was to investigate economy of gait during
submaximal treadmill walking in mild to moderate PD, and
the relationship between economy of gait and the distance
covered during the 6-minute walk (6MW).
2. Methods
2.1. Subjects. Participants for this study were recruited from
the University of Maryland Parkinson’s Disease Center and
the Baltimore VA Medical Center neurology clinics as part
of an exercise intervention trial in PD [11]. Inclusion criteria
were (1) diagnosis of levodopa-responsive PD characterized
by 2 of 3 cardinal signs (resting tremor, bradykinesia,
rigidity), (2) Hoehn and Yahr (HY) [12]s t a g e1t o3( w h i l e
“on” for motor ﬂuctuations), and (3) presence of mild to
moderate gait impairment, (score of 1 or 2 on Uniﬁed
Parkinson’sDiseaseRatingScale(UPDRS)[13]questionsno.2 Parkinson’s Disease
29 Gait or no. 30 Postural Stability, (4) Age ≥ 40, )5) Folstein
mini-mental state examination [14]s c o r e≥ 23, and (6)
unlikely to require PD medication adjustment for 4 months.
Exclusioncriteriawere(1)unstablecardiac,pulmonary,liver,
or renal disease, (2) unstable hypertension or diabetes, (3)
anemia, orthopedic, or chronic pain-restricting exercise, (4)
unstable psychiatric illness, or (5) >20 minutes of aerobic
exercise more than 3 times per week (to avoid prior training
eﬀect). This study was approved by the Institutional Review
Board at the University of Maryland, Baltimore, and written
informed consent was obtained from each participant.
All physical performance measures, rating scales, and
functional tests were performed while the subjects were “on”
or within 3 hours of medication intake. Subjects used an
additional dose of medication to maintain the “on” state
when necessary.
2.2. Assessments. The UPDRS was administered by a neu-
rologist with expertise in movement disorders (LS). The
Total UPDRS includes three subscales: Mentation, Behavior,
and Mood (Part I), Activities of Daily Living (Part II),
and the Motor Examination (Part III). Short distance
ambulatory function was assessed with three-timed 10 meter
walks. The self-selected walking speed was deﬁned as the
average velocity of the three tests. This short-distance test is
widely recognized as a valid index of mobility recovery and
simulates the distance required for many home-based daily
functions. The 6MW is a distance that is more representa-
tive of community-based daily activities. Participants were
instructedtocoverasmuchdistanceaspossiblein6minutes,
turning every 100 feet, as prompted by orange traﬃcc o n e s
set apart across a ﬂat, clear space.
2.3. Exercise Treadmill Testing
Screening Treadmill Test. A screening graded-treadmill test
to voluntary exhaustion without measurement of the rate of
oxygen consumption (VO2) was performed using a manual
protocol as previously described [15, 16]. All treadmill
testing was performed in the early afternoon while the
subjects were “on”. This screening exercise treadmill test
served to (1) acclimate the subjects to walking on a treadmill
(2) evaluate for symptoms of overt coronary disease or to
detect silent myocardial ischemia (3) evaluate hemodynamic
heartrateandbloodpressureresponsetoexercise(4)observe
gait patterns and (5) determine whether there were any
issues that would preclude their ability to safely exercise. All
subjectsworeagaitbeltforsafety,andaspotterstoodbehind
subjects during the treadmill evaluations. Subjects were
instructed to use the minimum level of handrail support for
balance during the test.
The initial target speed for treadmill testing was the
subject’s self-selected over ground walking velocity, with the
incline set at 0%. The ﬁrst stage was conducted for 2 minutes
at 0% grade, the next stage was conducted for 2 minutes at
4% grade, and then the grade was subsequently advanced
by 2% every minute until voluntary exhaustion. In frailer
subjects, the second stage was conducted at 2% instead of
4% for a more gradual increase in workload. Once the grade
reached10%,subjectswereaskedifthespeedofthetreadmill
could be simultaneously advanced with grade (generally
by 0.2mph). The electrocardiogram (ECG) was monitored
continuously, and blood pressure was measured during the
ﬁrst 3 stages of the tests and every 2 minutes during recovery.
Exercise Treadmill Test with Measurement of Peak Oxygen
Consumption. At the next study visit one week later, subjects
underwent a progressive-graded exercise treadmill test to
voluntary exhaustion as described above with measurement
of peak oxygen consumption (VO2 peak using a Quark Car-
dioPulmonaryExerciseTestingmetabolicanalyzer(Cosmed,
Rome, Italy)). In some subjects, the initial treadmill speed
was adjusted slightly based on the results of the screening
treadmill test and feedback from the research subjects. As
a result, the average self-selected walking speed on the
treadmill was 94% of their self-selected over ground speed
(2.31 ± 0.59 miles per hour (mph) versus 2.46 ± 0.53mph).
The ﬁrst stage was conducted for 2 minutes at 0% grade
(ﬁrst submaximal treadmill stage), and then advanced as
described above. O2 consumption, CO2 production, and
minute ventilation were measured breath-by-breath, and
values averaged for 20 second intervals. Subjects were
instructed not to talk during the test as this is known to
aﬀect the depth of breathing and gas exchange. Based on our
pilot study [15], we anticipated that we would not be able to
measure true maximal aerobic capacity (deﬁned as a plateau
inoxygenconsumptionduringtheﬁnalstage,maximalheart
rate >85% of age-adjusted predicted maximal heart rate,
and respiratory quotient (RQ) or respiratory exchange ratio
(RER) > 1.10) in many of these deconditioned subjects. The
VO2 peak was based on the mean of the ﬁnal two 20-second
averages obtained during the ﬁnal stage of the test.
2.4. Economy of Gait. We used the average O2 consumption
values obtained over the ﬁnal 40 seconds of the ﬁrst sub-
maximal treadmill stage to measure economy of gait. The
2-minute duration of this stage is similar to the time spent
on many activities of daily living. Economy of gait was
calculated as the measured VO2 during the ﬁrst treadmill
stage divided by the predicted VO2 for non-PD age-matched
subjects based on commonly accepted American College of
Sports Medicines equations for subjects walking accounting
for treadmill speed and grade [17].
VO2 = horizontal component + vertical component
+ resting component,
VO2 (mL/kg/min) = 0.1 (speed) + 1.8 (speed)
(fractional grade) + 3.5,
Speed = speed in meter/minute, to convert to mph,
1mph= 26.8meter/minute.
Higher oxygen consumption levels for any given speed
and treadmill grade imply increased energy expenditure and
impaired economy of gait.
2.5. Statistics. SAS version 9.2 (SAS Institute, Inc, Cary,
NC, USA) was used for the statistical analyses. DescriptiveParkinson’s Disease 3
statistics are expressed as mean ± standard deviation (SD).
Pearson’s correlation coeﬃcients were used to calculate
strength of relationship between variables. All statistical tests
were two sided and performed at a signiﬁcance level of 0.05.
3. Results
Seventy-nine subjects (57 men and 22 women) completed
this cross-sectional study. Physical characteristics and PD
severity scores are summarized in Table 1. Based on the
UDPRS and HY ratings, the subjects had a broad range
of disease severity from mild to moderately severe PD.
Eleven subjects (7%) had received deep brain stimulation
surgery for PD. The level of medical comorbidity in the
sample was low, with only ﬁve individuals (6%) with prior
history of stable coronary artery disease, seven (10%) on
medication for diabetes, and only one was a current smoker
(1%). Twenty-nine subjects (37%) were on medications for
hypertension, including ﬁve on betablockers.
The VO2 at the self-selected treadmill walking speed
averaged64%oftheirVO2 peak. There were, however, a wide
range of values (31% to 89% of VO2 peak). Interestingly,
24 of 79 subjects had submaximal VO2 levels that exceeded
70% of their VO2 peak, indicating severe reduction in
economy of gait, with 3 subjects approaching 90% of their
VO2 peak. Overall the subjects had mean submaximal, self-
selected walking speed VO2 values that were 51% higher
than the VO2 levels expected for the same speed and grade
for non-PD subjects (13.0 ± 3.3mL/kg/min versus 9.7 ±
1.6m/kg/min). This observation provides clear evidence of
the large decreases in economy caused by parkinsonian gait
patterns (Figure 1).
We examined whether PD severity was associated with
economy of gait (the ratio of measured VO2 and predicted
VO2). There was a signiﬁcant correlation of HY stage
with economy of gait (Figure 2)w i t hm o r ea d v a n c e dP D
severity associated with lower economy of gait. There was
no relationship between economy of gait with total or motor
UPDRS. There was an inverse relationship between economy
of gait and the distance covered during the 6MW (r =
−0.31, P<0.01). Speciﬁcally, individuals whose measured
VO2 was a higher percentage of their VO2 peak during their
self-selected walking speed covered less distance walking for
six minutes (Figure 3). There was also an inverse relationship
between walking speed on the treadmill test and economy of
gait (r =− 0.35, P<0.01).
4. Discussion
Our results demonstrate that economy of gait is markedly
impaired in people with mild to moderate PD that increases
theenergydemandsofphysicalactivity.Oursubjectswalking
at their self-selected pace on the treadmill required on
average 64% of their VO2 peak. Indeed, 30% of our subjects
used over 70% of their VO2 peak during their self-selected
treadmill speed, and several subjects approached 90% of
their VO2 peak. By contrast in healthy younger and older
individuals, most activities require a small percentage of
Table 1: Subject characteristics, disease severity, and physical
performance measures.
Parameter (N = 79∗) Mean ± SD Range
Age (years) 65.1 ± 10.7 42 to 86
UPDRS total 47.2 ± 14 15 to 96
UPDRS motor 32.4 ± 10.2 11 to 66
Hoehn and Yahr stage 2.2 ± 0.4 1.5 to 3.0
Hoehn and Yahr Stage 1.5 N = 1( 1 % ) —
Hoehn and Yahr Stage 2.0 N = 61 (77%) —
Hoehn and Yahr Stage 2.5 N = 5( 6 % ) —
Hoehn and Yahr Stage 3.0 N = 12 (15%) —
Body mass index (kg/m2) 28.1 ± 4.9 18.0 to 41.6
VO2 peak (mL/kg/min) 22.4 ± 4.8 12.6 to 37.4
Submaximal VO2 (mL/kg/min) 13.0 + 3.3 5.1 to 21.6
Walking speed (mph) 2.31 ± 0.59 1.0 to 3.8
6min walk distance (meters) 424 ± 106 122 to 695
∗6-min walk performed in 75 subjects.
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Figure 1:SubmaximalVO2 measuredatself-selectedwalkingspeed
during the last 40 seconds of the ﬁrst 2-minute stage of treadmill
testversuswalkingspeedinmph.Diamondsshowmeasuredvalues,
where solid line shows expected value (VO2 mL/kg/min predicted =
0.1 × 26.8 speed in mph + 3.5). The vast majority of subjects had
measured values higher than the predicted values indicative of poor
economy of gait.
the maximal or peak working capacity as indexed by their
VO2 peak [18, 19]. In a study of seniors without PD, the
percentage of oxygen uptake (VO2/VO2 peak) during low,
moderate and high workload levels was 32%, 42%, and 50%,
respectively[20].Inthatstudy,VO2 atthefastestcomfortable
walking speed was 40% of VO2 peak, values substantially
lower than those observed in our subjects with mild to
moderate PD.
There was a relationship between HY stage and economy
ofgait,suchthatindividualswithmoreseverePDhadpoorer
economyofgait.Impairmentsingaitandmobilityimpacton
the ability of subjects with PD to perform a number of gait-
dependent daily activities including housework, dressing,
and transferring in and out of bed [21]. Impaired gait4 Parkinson’s Disease
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Figure 2: Relationship between the Hoehn and Yahr stage and
economy of gait (ratio of measured VO2 to predicted VO2). Higher
values of the ratio of measured VO2 to predicted VO2 are indicative
of impaired economy of gait.
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Figure 3: There was an inverse relationship between the distance
covered during the 6min walk (6MW) and the amount of oxygen
subjects consumed at their self-selected walking speed during the
ﬁrst stage of the treadmill expressed as a percentage of their VO2
peak.
economy may result from many factors including abnormal
gait biomechanics and altered spatiotemporal aspects of gait
associated with PD, that is, slow, short-stepped shuﬄing
gait with decreased stride length, asymmetric arm [22]
swing, tremor and rigidity, postural instability, loss of
range of motion of axial structures, impaired sensorimotor
integration, and so forth, The modest association between
economy of gait and disease severity and economy of gait
and distance covered during the 6MW test also indicates
that other factors such as balance problems, diﬃculty with
turning, and physical deconditioning contribute to impaired
mobility in these subjects [1–3].
Few studies have directly measured walking economy
in PD. Christiansen et al. examined walking economy at a
number of walking speeds in subjects with PD compared
to healthy subjects without PD [10]. VO2 was found to
be 6 to 10% higher in people with PD at walking speeds
above 1mph. We report much greater impairments in
walking economy than Christiansen et al. The VO2 for our
subjects at 2mph is 12.5mL/kg/min, whereas Christiansen
et al. reported a VO2 of 11mL/kg/min at this speed. This
diﬀerence may be explained by greater PD severity in
our population (mean total UPDRS score, 47 versus 32).
We used published equations for VO2 rather than direct
measurement in a control population. The predicted VO2
for a given walking speed derived from younger individuals
may underestimate the energy cost of walking in healthy
older adults [19]. Protas et al. [23] also studied submaximal
oxygen consumption during steady-state exercise in PD.
Exercise performance was assessed using cycle ergometry in
P Da n dn o n - P D .T h eP Dg r o u pw a su n a b l et op e r f o r mt h e
same level of exercise as rated by maximum power when
compared with the control group, even though the peak
VO2 and heart rate were similar. The authors concluded that
there was poorer exercise eﬃciency in the PD group than
in controls. Over a range of submaximal cycling intensities,
rates of energy expenditure were about 20% higher in PD
than in controls. Thus, our results support previous ﬁndings
of reduced economy of gait and exercise eﬃciency in PD.
There is growing interest in the eﬀects of aging and
medical comorbidities on bioenergetics and their impact
on mobility and other measures of physical performance
[18, 24]. We have previously reported that subjects with mild
to moderate PD have VO2 peak values 20 to 25% lower than
healthy age-matched controls [16]. This impairment in VO2
peak, in combination with the higher energy demands of
walking (lower economy of gait), reduces the physiologic
reserve in PD. The decreased physiologic reserve and lower
VO2 peak make it more diﬃcult to perform everyday tasks.
The higher energy cost of walking necessitates the use of
anaerobicpathwaystomeetordinaryenergydemands,which
maybeassociatedwithfatigue[18,20].Clearly,thedecreased
physiological reserve shown in this study has functional
consequences as evidenced by impaired 6MW distance and
slow self-selected walking speed, particularly in those with
more severe PD. The predicted 6MW distance for healthy
subjects without PD using the equation of Enrichi and
Sherrill[25]thattakesintoconsiderationage,gender,height,
and weight was 509 meters compared to the measured 424
meters, a diﬀerence of 85 meters, or 17% lower in PD. The
6MW distance in our subjects is comparable to the values
reported by Falvo and Earhart [26]w h or e p o r t e da6M W
distance of 394.1 ± 98.4m in PD patients of similar age to
our subjects.
This study has limitations that may result in an under-
estimation of the severity of the impairment of economy
of gait. (1) The submaximal O2 utilization was measured
by using O2 utilization during the last 40 seconds of the
ﬁrst stage of the treadmill test, when subjects walked at
their self-selected speed and 0% grade. We chose this time
as representative of the time period in which our subjects
typically walked. A number of investigators have advocated
measuring submaximal O2 for longer periods of time [7,
18, 27]. For example, Alexander et al. measured O2 kinetics
in frail and non-frail older adults during a 6-minute sub-
maximal exercise bout on the treadmill [7]. The Baltimore
Longitudinal Study of Aging employs a 5-minute stage, but
the data from the ﬁrst 1.5 minutes is discarded [18]. This
allows for a longer period of time for the subjects to come
to equilibrium and plateau during the bout of submaximal
exercise. We recognize that it is possible that some of subjectsParkinson’s Disease 5
did not plateau during the second minute of the exercise
due to a lag in O2 uptake at the start of exercise reﬂecting
impaired O2 kinetics. However, any error introduced would
havebiasedourmeasuringlessO2 utilizationassubjectswith
delayedO2 kineticswouldtakelongertocometoequilibrium
[7, 27]. Hence, we potentially understated the degree of
ineﬃciency of our patient sample with respect to economy
of gait. (2) Another limitation is that the O2 consumption
during exercise includes a resting component for the resting
metabolic rate. Indeed this resting component is included in
the AmericanCollege of Sports Medicine equation[17].This
resting component is often measured with the subjects in the
supine position [28], but others have advocated measuring it
byhavingthesubjectstandfor5minutespriortothewalking
test [9] as this allows an examination of the incremental
O2 utilization attributable to the exercise itself. The resting
metabolic rate in subjects with PD might be aﬀected by age-
related changes in body composition, sarcopenia, as well as
other changes attributable to PD (i.e., resting tremor and
medication eﬀects). Changes in resting metabolic rate in PD
may be clinically signiﬁcant as a higher resting metabolic
rate is associated with increased mortality in older adults
[28]. Even if the increased metabolic needs during exercise
are partially explained by an increased resting metabolic
rate, the net eﬀect on ambulatory function is the same;
more energy is needed for a given level of ambulation. (3)
Another potential confound is the use of handrail support
during this study. Subjects were instructed to walk on the
treadmill with minimal hand support. Subjects varied in the
extent to which they used the side rails for balance support.
The use of hand support reduces O2 consumption, again
leading to a possible underestimate of their O2 utilization
(VO2) and subsequent underestimate of the degree of
impairment of their economy of gait. (4) These measures
wereperformedwithsubjectswalkingontreadmills.Frenkel-
Toledo et al. have proposed that treadmill walking may act
as an external pacemaker to improve gait variability [29].
If gait biomechanics improve on the treadmill, this would
reduceoxygenutilization and lead to an overestimate of their
economyofgait.Thegaitbiomechanicsandenergeticsmight
be diﬀerent in overground walking. (5) Lastly the 6-minute
walktestrequiredsubjectstomaketightturnsaroundacone.
This might have adversely impacted the distance covered,
particularly in subjects that had limited ability to turn, that
is, turning “en bloc”. Future studies employing portable
metabolic systems could be employed to examine economy
of gait during overground walking.
There is substantial interest in whether the abnormalities
ingaitandfunctionalperformanceinPDcanbeimprovedby
treadmillexercisetraining[30–32].InapilotstudybyPelosin
et al. [32], 10 patients with idiopathic PD underwent 4 weeks
oftreadmilltraining(30min,threetimesaweekfor4weeks).
Walking performance (Timed Up and Go, 6-min and 10-m
walking tests) and metabolic function (oxygen uptake and
heart and respiratory rate) were evaluated before training,
at the end of treatment and after 30 days with two diﬀerent
graded exercises (treadmill and cycle ergometer). Training
signiﬁcantlyimprovedwalkingperformance.Oxygenuptake,
and heart and respiratory rates were signiﬁcantly decreased
only during graded exercise on the treadmill but not on the
cycle ergometer consistent with improved economy of gait,
but the data are diﬃcult to interpret due to the way they are
displayed in the paper.
Insummary,thisstudyreinforcespriorevidenceshowing
impaired economy of gait in PD that is associated with
impairment of ambulation at both short and long distance.
Reduced economy of gait combined with the reduced
VO2 peak results in lower physiologic reserve where even
comfortable gait is performed at a high percentage of VO2
peak.Futureresearchshouldexaminethebiomechanicaland
neuromuscular factors that contribute to impaired walking
economy in PD. A better understanding of these factors may
lead to new approaches to improve functional performance
and quality of life in PD.
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